New virtual screening strategy identifies existing drug that inhibits Covid-19 virus
In lab experiments, pralatrexate outperforms remdesivir against SARS-CoV-2
2021-01-02
(Press-News.org) A novel computational drug screening strategy combined with lab experiments suggest that pralatrexate, a chemotherapy medication originally developed to treat lymphoma, could potentially be repurposed to treat Covid-19. Haiping Zhang of the Shenzhen Institutes of Advanced Technology in Shenzhen, China, and colleagues present these findings in the open-access journal PLOS Computational Biology.
With the Covid-19 pandemic causing illness and death worldwide, better treatments are urgently needed. One shortcut could be to repurpose existing drugs that were originally developed to treat other conditions. Computational methods can help identify such drugs by simulating how different drugs would interact with SARS-CoV-2, the virus that causes Covid-19.
To aid virtual screening of existing drugs, Zhang and colleagues combined multiple computational techniques that simulate drug-virus interactions from different, complimentary perspectives. They used this hybrid approach to screen 1,906 existing drugs for their potential ability to inhibit replication of SARS-CoV-2 by targeting a viral protein called RNA-dependent RNA polymerase (RdRP).
The novel screening approach identified four promising drugs, which were then tested against SARS-CoV-2 in lab experiments. Two of the drugs, pralatrexate and azithromycin, successfully inhibited replication of the virus. Further lab experiments showed that pralatrexate more strongly inhibited viral replication than did remdesivir, a drug that is currently used to treat some Covid-19 patients.
These findings suggest that pralatrexate could potentially be repurposed to treat Covid-19. However, this chemotherapy drug can prompt significant side effects and is used for people with terminal lymphoma, so immediate use for Covid-19 patients is not guaranteed. Still, the findings support the use of the new screening strategy to identify drugs that could be repurposed.
"We have demonstrated the value of our novel hybrid approach that combines deep-learning technologies with more traditional simulations of molecular dynamics," Zhang says. He and his colleagues are now developing additional computational methods for generating novel molecular structures that could be developed into new drugs to treat Covid-19.
INFORMATION:
Peer-reviewed; Simulation/modelling
In your coverage please use this URL to provide access to the freely available article in PLOS Computational Biology:
http://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1008489
Citation: Zhang H, Yang Y, Li J, Wang M, Saravanan KM, Wei J, et al. (2020) A novel virtual screening procedure identifies Pralatrexate as inhibitor of SARS-CoV-2 RdRp and it reduces viral replication in vitro. PLoS Comput Biol 16(12): e1008489.
https://doi.org/10.1371/journal.pcbi.1008489
Funding: This work was partly supported by the National Key Research and Development Program of China under Grant No. 2018YFB0204403 (Y.W.) and 2019YFA0906100 (X.W.); Strategic Priority CAS Project XDB38000000 to Y.W., National Science and Technology Major Project under Grant No. 2018ZX10101004 (Y.Y.), National Science Foundation of China under Grant no. U1813203 (Y.W.); the National Natural Youth Science Foundation of China (Grant no. 31601028: Y.P.); the Shenzhen Basic Research Fund under Grant no. JCYJ20190807170801656 (J.L.), JCYJ20180507182818013 (Y.W.), JCYJ20170413093358429 (Y.W.), and the SIAT Innovation Program for Excellent Young Researchers (J.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: No authors have competing interests.
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2021-01-02
Multiple bouts of blood feeding by mosquitoes shorten the incubation period for malaria parasites and increase malaria transmission potential, according to a study published December 31 in the open-access journal PLOS Pathogens by Lauren Childs of Virginia Tech, Flaminia Catteruccia of the Harvard T.H. Chan School of Public Health, and colleagues. Given that mosquitoes feed on blood multiple times in natural settings, the results suggest that malaria elimination may be substantially more challenging than suggested by previous experiments, which typically involve a single blood meal.
Malaria ...
2021-01-02
The discovery of new drugs is vital to achieving the eradication of neglected tropical diseases (NTDs) in Africa and around the world. Now, researchers reporting in PLOS Neglected Tropical Diseases have identified traditional Ghanaian medicines which work in the lab against schistosomiasis, onchocerciasis and lymphatic filariasis, three diseases endemic to Ghana.
The major intervention for NTDs in Ghana is currently mass drug administration of a few repeatedly recycled drugs, which can lead to reduced efficacy and the emergence of drug resistance. Chronic infections of schistosomiasis, onchocerciasis and lymphatic filariasis ...
2021-01-02
In the ongoing arms race between humans and the parasite that causes malaria, Taane Clark and colleagues at the London School of Hygiene and Tropical Medicine (LSHTM) report that new mutations that enhance resistance to a drug used to prevent malaria in pregnant women and children are already common in countries fighting the disease. The new results are published December 31 in PLOS Genetics.
Malaria causes about 435,000 deaths each year, primarily in young children in sub-Saharan Africa. Despite a long-term global response, efforts to control the disease are hampered by the rise of drug-resistant strains of the parasite species that cause malaria. Sulfadoxine-pyrimethamine (SP), ...
2021-01-02
UNIVERSITY PARK, Pa. -- A desalination membrane acts as a filter for salty water: push the water through the membrane, get clean water suitable for agriculture, energy production and even drinking. The process seems simple enough, but it contains complex intricacies that have baffled scientists for decades -- until now.
Researchers from Penn State, The University of Texas at Austin, Iowa State University, Dow Chemical Company and DuPont Water Solutions published a key finding in understanding how membranes actually filter minerals from water, online today (Dec. 31) in Science. The article will be featured on the print edition's cover, to be issued tomorrow (Jan. ...
2021-01-02
Predicting when and how collections of particles, robots, or animals become orderly remains a challenge across science and engineering.
In the 19th century, scientists and engineers developed the discipline of statistical mechanics, which predicts how groups of simple particles transition between order and disorder, as when a collection of randomly colliding atoms freezes to form a uniform crystal lattice.
More challenging to predict are the collective behaviors that can be achieved when the particles ...
2021-01-02
High in the clouds, atmospheric aerosols, including anthropogenic air pollutants, increase updraft speeds in storm clouds by making the surrounding air more humid, a new study finds. The results offer a new mechanism explaining the widely observed - but poorly understood - atmospheric phenomenon and provide a physical basis for predicting increasing thunderstorm intensity, particularly in the high-aerosol regions of the tropics. Observations worldwide have highlighted aerosols' impact on weather, including their ability to strengthen convection in deep convective clouds, like those ...
2021-01-02
A new analysis suggests that, by 2040, 19% of the world's population - accounting for 21% of the global Gross Domestic Product - will be impacted by subsidence, the sinking of the ground's surface, a phenomenon often caused by human activities such as groundwater removal, and by natural causes as well. The results, reported in a Policy Forum, represent "a key first step toward formulating effective land-subsidence policies that are lacking in most countries worldwide," the authors say. Gerardo Herrera Garcia et al. performed a large-scale ...
2021-01-02
When the COVID-19 pandemic reached Africa, the continent was already struggling to deal with another public health crisis - a growing cancer epidemic characterized by more than one million new cancer cases and nearly 700,000 deaths per year. In a Perspective, Beatrice Wiafe Addai and Wilfred Ngwa discuss the significant challenges COVID-19 imposed on cancer prevention and control in Africa and how the efforts to address these challenges highlight key opportunities where greater investment could improve cancer care globally. At the start of the pandemic, many African ...
2021-01-02
Overcoming a key obstacle in achieving diamond-based electronic and optoelectronic devices, researchers have presented a new way to fabricate micrometer-sized diamonds that can elastically stretch. Elastic diamonds could pave the way for advanced electronics, including semiconductors and quantum information technologies. In addition to being the hardest materials in nature, diamonds have exceptional electronic and photonic properties, featuring both ultrahigh thermal and electric conductivity. Not only would diamond-based electronics dissipate heat more quickly, reducing the need for ...
2021-01-02
CHAPEL HILL, NC--Boosting immune system T cells to effectively attack solid tumors, such as breast cancers, can be done by adding a small molecule to a treatment procedure called chimeric antigen receptor-T (CAR-T) cell therapy, according to a study by researchers at the UNC Lineberger Comprehensive Cancer Center. The boost helps recruit more immune cells into battle at the tumor site. The findings are published in the Journal of Experimental Medicine.
CAR-T immunotherapy, in which T cells are modified in the laboratory to express chimeric antigen receptors, CARs, that in turn target surface proteins ...
LAST 30 PRESS RELEASES:
[Press-News.org] New virtual screening strategy identifies existing drug that inhibits Covid-19 virus
In lab experiments, pralatrexate outperforms remdesivir against SARS-CoV-2
